NO20065923L - Doseringsform for avlevering av multiple legemiddelformer - Google Patents

Doseringsform for avlevering av multiple legemiddelformer

Info

Publication number
NO20065923L
NO20065923L NO20065923A NO20065923A NO20065923L NO 20065923 L NO20065923 L NO 20065923L NO 20065923 A NO20065923 A NO 20065923A NO 20065923 A NO20065923 A NO 20065923A NO 20065923 L NO20065923 L NO 20065923L
Authority
NO
Norway
Prior art keywords
pharmaceutically acceptable
acceptable salt
delivery
dosage form
multiple drug
Prior art date
Application number
NO20065923A
Other languages
English (en)
Inventor
David Edgren
Bih-Hsiung Hsu
Shu Li
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20065923L publication Critical patent/NO20065923L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Angitt er kontrollerte frigjøringsdoseringsformer og relaterte fremgangsmåter som inkluderer: (a) en rnikronisert eller flytende baseform av et medikament; (b) enten en farmasøytisk akseptabel saltform av medikamentet eller utgangsmaterialer som er i stand til å reagere for å danne en farmasøytisk akseptabel saltform av medikamentet; (c) en øvre gastrointestinal system farmasøytisk akseptabel saltform frigjørende struktur; og (d) en kolonsystem baseform frigjørende struktur.
NO20065923A 2004-05-21 2006-12-20 Doseringsform for avlevering av multiple legemiddelformer NO20065923L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57331204P 2004-05-21 2004-05-21
PCT/US2005/017678 WO2005112896A2 (en) 2004-05-21 2005-05-20 Dosage form for delivery of multiple drug forms

Publications (1)

Publication Number Publication Date
NO20065923L true NO20065923L (no) 2007-02-13

Family

ID=35159875

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065923A NO20065923L (no) 2004-05-21 2006-12-20 Doseringsform for avlevering av multiple legemiddelformer

Country Status (13)

Country Link
US (1) US20050260264A1 (no)
EP (1) EP1750678A2 (no)
JP (1) JP2008506788A (no)
KR (1) KR20070013316A (no)
CN (1) CN1960709A (no)
AU (1) AU2005244966A1 (no)
BR (1) BRPI0510034A (no)
CA (1) CA2565253A1 (no)
IL (1) IL179456A0 (no)
MX (1) MXPA06013397A (no)
NO (1) NO20065923L (no)
WO (1) WO2005112896A2 (no)
ZA (1) ZA200610770B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
DK1803443T3 (en) 2002-12-20 2019-02-25 Niconovum Ab Nicotine-containing particulate material with a crystalline cellulose
US20050287214A1 (en) * 2004-06-28 2005-12-29 Ayer Atul D Squeeze controlled oral dosage form
CA2646942C (en) 2006-03-16 2014-07-29 Modoral Brands Inc. Improved snuff composition
US8637080B2 (en) * 2007-06-28 2014-01-28 Osmotica Kereskedelmi és Szolgáltató, KFT Rupturing controlled release device comprising a subcoat
EP2247283A2 (en) * 2007-12-06 2010-11-10 Pain Therapeutics, Inc. Micronized opioid compositions, formulations and dosage forms and methods of making same
WO2009075782A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US8833378B2 (en) * 2008-09-17 2014-09-16 Niconovum Ab Process for preparing snuff composition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US20120128730A1 (en) * 2010-11-23 2012-05-24 Nipun Davar Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US12274794B2 (en) 2016-07-06 2025-04-15 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
US10716761B2 (en) 2017-07-24 2020-07-21 Alcresta Therapeutics, Inc. Ingestible medical delivery devices
JP2019026726A (ja) * 2017-07-28 2019-02-21 富士ゼロックス株式会社 樹脂組成物及び樹脂成形体
US12161146B2 (en) 2020-02-18 2024-12-10 Intrepid Brands Llc Synthetic fiber oral flavored product
WO2023205692A1 (en) * 2022-04-19 2023-10-26 Intrepid Brands, LLC Liquid formulations for oral flavored product

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
NZ537543A (en) * 2002-07-29 2007-08-31 Alza Corp Formulations and high dose osmotic dosage forms for controlled delivery of topiramate

Also Published As

Publication number Publication date
IL179456A0 (en) 2007-05-15
KR20070013316A (ko) 2007-01-30
WO2005112896A3 (en) 2006-05-18
AU2005244966A1 (en) 2005-12-01
MXPA06013397A (es) 2007-01-23
JP2008506788A (ja) 2008-03-06
US20050260264A1 (en) 2005-11-24
EP1750678A2 (en) 2007-02-14
CA2565253A1 (en) 2005-12-01
ZA200610770B (en) 2008-08-27
WO2005112896A2 (en) 2005-12-01
BRPI0510034A (pt) 2007-10-02
CN1960709A (zh) 2007-05-09

Similar Documents

Publication Publication Date Title
MX2015011896A (es) Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia.
MA32692B1 (fr) Procede de liberation d'une composition pharmaceutique a un patient qui en a besoin
CY1126112T1 (el) Φαρμακοτεχνικες μορφες που περιεχουν ενυδρη προπυλενογλυκολη δαπαγλιφλοζινης
WO2005112896A3 (en) Dosage form for delivery of multiple drug forms
NO20090593L (no) Modulatorer av farmakokinetikkegenskaper til terapeutika
NO20050835L (no) Varmsmelte TTS for administrasjon av rotigotin
NO20100250L (no) Farmasoytisk preparat som innbefatter en S1P reseptoragonist og en sukkeralkohol, og framgangsmate til fremstilling derav
AR061967A1 (es) Ester isopropilico del acido 4-[6-(6-metanosulfonil-2-metil-piridin-3-il-amino)-5-metil-pirimidin-4-iloxi]-piperidin-i-carboxilico, composicion farmaceutica que lo comprende y un metodo de preparacion de la misma y el uso de este compuesto para el tratamiento de trastornos metabolicos
NO20062713L (no) 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister
NO20071175L (no) Sammensetning for langvarig medikamentfrigivning som viser et okende null-bestillende frigivningsmonster, fremgangsmate for fremstilling av en slik sammensetning
MX2010001812A (es) Farmacos resistentes al abuso, metodo de uso y metodo de fabricacion.
ATE497745T1 (de) Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren
DK1957110T3 (da) Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed
NO20070588L (no) Piperidinderivater som NK1-antagonister.
AR069031A1 (es) Composicion
NO20084049L (no) Forbindelser med forsterket ampa receptor og anvendelse derav i medisin
TW200738228A (en) Neramexane modified release matrix tablet
MX2011008188A (es) Composicion farmaceutica para administracion oral.
EA200801909A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
EP4473987A4 (en) Device for administering a medicinal solution
NO20065880L (no) 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
WO2007048223A3 (en) A gastric retention drug delivery system
AR055099A1 (es) Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
CY1109939T1 (el) Εκ του στοματος χορηγουμενη μορφη δοσολογιας για ελεγχομενη αποδεσμευση φαρμακου